Skip to contentApplication 206665
- Type
- ANDA
- Sponsor
- ANCHEN PHARMS
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ALISKIREN HEMIFUMARATE | ALISKIREN HEMIFUMARATE | TABLET;ORAL | EQ 150MG BASE | No | No |
| 002 | ALISKIREN HEMIFUMARATE | ALISKIREN HEMIFUMARATE | TABLET;ORAL | EQ 300MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 49884-424 | ALISKIREN | ALISKIREN | Par Pharmaceutical, Inc. | ANDA | Current |
| 49884-425 | ALISKIREN | ALISKIREN | Par Pharmaceutical, Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 58403 | ORIG | 2019-04-24 |